We are live on ! Find out more
WIC

Wilkins Investment Counsel Portfolio holdings

AUM $742M
1-Year Est. Return 23.98%
This Fund
S&P 500
This Quarter Est. Return
+9.17%
1 Year Est. Return
+23.98%
3 Year Est. Return
+56.19%
5 Year Est. Return
+63.91%
10 Year Est. Return
+187.24%
AUM
$742M
AUM Growth
+$43.8M
Cap. Flow
+$1.68M
Cap. Flow %
0.23%
Top 10 Hldgs %
33.55%
Holding
122
New
3
Increased
20
Reduced
55
Closed
3

Top Buys

Rank Stock Value
1
ACN icon
Accenture
ACN
+$6.96M
2
FISV
Fiserv Inc
FISV
+$3.04M
3
MDT icon
Medtronic
MDT
+$1.74M
4
CPRT icon
Copart
CPRT
+$1.31M
5
IQV icon
IQVIA
IQV
+$865K

Top Sells

Rank Stock Value
1
FTNT icon
Fortinet
FTNT
+$4.3M
2
NTRS icon
Northern Trust
NTRS
+$1.15M
3
TXN icon
Texas Instruments
TXN
+$1.07M
4
ILMN icon
Illumina
ILMN
+$777K
5
CSCO icon
Cisco
CSCO
+$701K

Sector Composition

Rank Sector Weight
1 Healthcare 20.26%
2 Technology 19.66%
3 Industrials 12.94%
4 Materials 11.92%
5 Financials 10.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEM icon
1
Newmont
NEM
$111B
$34.9M 4.7%
373,570
-5,060
-1% -$551K
MRK icon
2
Merck
MRK
$317B
$31.4M 4.23%
244,471
-2,277
-0.9% -$267K
CTVA icon
3
Corteva
CTVA
$51.3B
$26.7M 3.6%
315,721
-2,670
-0.8% -$214K
CB icon
4
Chubb
CB
$137B
$25.4M 3.42%
74,439
-290
-0.4% -$94.6K
NTRS icon
5
Northern Trust
NTRS
$33.7B
$23M 3.09%
132,071
-7,002
-5% -$1.15M
MMM icon
6
3M
MMM
$93.2B
$22.9M 3.08%
141,274
-405
-0.3% -$61.4K
ILMN icon
7
Illumina
ILMN
$29.3B
$22.2M 2.99%
126,275
-5,310
-4% -$777K
IBM icon
8
IBM
IBM
$220B
$21.5M 2.9%
76,408
-365
-0.5% -$92K
WMB icon
9
Williams Companies
WMB
$87.8B
$21M 2.82%
281,880
-7,450
-3% -$548K
PG icon
10
Procter & Gamble
PG
$342B
$20M 2.7%
136,480
-1,152
-0.8% -$168K
ADP icon
11
Automatic Data Processing
ADP
$109B
$19.4M 2.61%
86,494
+343
+0.4% +$73.3K
IFF icon
12
International Flavors & Fragrances
IFF
$21.6B
$18.2M 2.45%
229,311
-1,353
-0.6% -$101K
FTNT icon
13
Fortinet
FTNT
$117B
$17.5M 2.36%
114,145
-37,178
-25% -$4.3M
MDT icon
14
Medtronic
MDT
$110B
$17.4M 2.35%
222,957
+21,536
+11% +$1.74M
NVS icon
15
Novartis
NVS
$293B
$17.4M 2.35%
111,067
-1,610
-1% -$241K
BP icon
16
BP
BP
$109B
$17M 2.29%
459,217
-4,125
-0.9% -$181K
JNJ icon
17
Johnson & Johnson
JNJ
$619B
$17M 2.29%
66,797
-297
-0.4% -$69.2K
IQV icon
18
IQVIA
IQV
$38.3B
$16.8M 2.26%
86,927
+4,958
+6% +$865K
EMR icon
19
Emerson Electric
EMR
$87.5B
$16.7M 2.25%
116,748
-800
-0.7% -$113K
UPS icon
20
United Parcel Service
UPS
$87.7B
$16.2M 2.18%
150,682
-390
-0.3% -$40.5K
PEP icon
21
PepsiCo
PEP
$189B
$14.8M 2%
109,640
-340
-0.3% -$50.8K
Q
22
Qnity Electronics Inc
Q
$27.9B
$14.8M 2%
90,874
-2,549
-3% -$375K
TXN icon
23
Texas Instruments
TXN
$254B
$13.5M 1.82%
45,292
-3,844
-8% -$1.07M
TECH icon
24
Bio-Techne
TECH
$11.2B
$13.4M 1.8%
189,412
+15,297
+9% +$826K
SLB icon
25
SLB Ltd
SLB
$76.5B
$12.8M 1.72%
274,465
-2,345
-0.8% -$126K

Similar funds

Wilkins Investment Counsel's Q2 2026 Portfolio in Review

As of Q2 2026, Wilkins Investment Counsel held 122 positions worth $742M, up 6.3% from $698M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 4.9%. Wilkins Investment Counsel opened 3 new positions and exited 3, leaving the 122-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.

  • Wilkins Investment Counsel's largest Q2 2026 buy was Honeywell Aerospace: 1,635 shares worth $361K.
  • Wilkins Investment Counsel added most to Accenture in Q2 2026, an estimated $6.96M increase.
  • Wilkins Investment Counsel's biggest Q2 2026 reduction was Fortinet, cutting an estimated $4.3M.
  • Wilkins Investment Counsel fully exited Corning in Q2 2026, selling an estimated $279K.
  • Wilkins Investment Counsel's ten largest holdings make up 34% of its $742M portfolio in Q2 2026.
  • Wilkins Investment Counsel opened 3 new positions and closed 3 in Q2 2026.
  • Wilkins Investment Counsel's portfolio value rose 6.3% quarter-over-quarter to $742M.

Based on Wilkins Investment Counsel's 13F filing for Q2 2026, filed 6 Aug 2026.